Sustained-release bupropion for smoking cessation in a Chinese sample: A double-blind, placebo-controlled randomized trial

Nicotine and Tobacco Research

Volumn 15, Issue 2, 2013, Pages 320-325

  Sheng, Li Xia ^a,b,c   Tang, Yi Lang ^a,d   Jiang, Zuo Ning ^a,b   Yao, Chong Hua ^e   Gao, Jun Yu ^f   Xu, Guo Zhu ^g   Tong, Xin Yuan ^h  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b National Institute of Drug Dependence   (China)

^c National Center for Clinical Trials of Psychotropic Drugs   (China)

^d EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e CAPITAL MEDICAL UNIVERSITY   (China)

^f BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

^g PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^h Department of Medical Statistics   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; COTININE; PLACEBO;

ADULT; ANXIETY; ARTICLE; CENTRAL NERVOUS SYSTEM DISEASE; CHINESE; CONTROLLED STUDY; COUNSELING; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG TOLERABILITY; ERECTILE DYSFUNCTION; FEMALE; GASTROINTESTINAL DISEASE; HEALTH EDUCATION; HUMAN; HUMAN EXPERIMENT; HYPERTENSION; INSOMNIA; MALE; MOUTH ULCER; NAUSEA; OUTPATIENT; PATIENT COMPLIANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SELF REPORT; SIDE EFFECT; SKIN DEFECT; SKIN VESICLE; SMOKING; SMOKING CESSATION; SUSTAINED DRUG RELEASE; THROAT DISEASE; URINE LEVEL; WITHDRAWAL SYNDROME; XEROSTOMIA;

ADULT; BUPROPION; CHINA; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; PLACEBOS; SMOKING CESSATION; TREATMENT OUTCOME;

EID: 84872859662     PISSN: 14622203     EISSN: 1469994X     Source Type: Journal    
DOI: 10.1093/ntr/nts124     Document Type: Article

References (26)

1. Ahluwalia, J. S., Richter, K., Mayo, M. S., Ahluwalia, H. K., Choi, W. S., et al. (2002). African American smokers interested and eligible for a smoking cessation clinical trial: Predictors of not returning for randomization. Annals of Epidemiology, 12, 206-212. doi:10.1016/S1047-2797(01)00305-2.
2. Bolliger, C. T., Zellweger, J. P., Danielsson, T., van Biljon, X., Robidou, A., Westin, A., et al. (2002). Influence of long-term smoking reduction on health risk markers and quality of life. Nicotine & Tobacco Research, 4, 433-439. doi: 10.1080/1462 220021000018380.
3. Broms, U., Korhonen, T., & Kaprio, J. (2008). Smoking reduction predicts cessation: Longitudinal evidence from the Finnish adult twin cohort. Nicotine & Tobacco Research, 10, 423-427. doi: 10.1080/14622200801888988.
4. Brown, R. A., Niaura, R., Lloyd-Richardson, E. E., Strong, D. R., Kahler, C. W., Abrantes, A. M., et al. (2007). Bupropion and cognitive-behavioral treatment for depression in smoking cessation. Nicotine & Tobacco Research, 9, 721-730. doi:10.1080/14622200701416955.
5. Fagerstrom, K. O., & Schneider, N. G. (1989). Measuring nicotine dependence: A review of the Fagerstrom Tolerance Questionnaire. Journal of Behavioral Medicine, 12, 159 - 182. doi:10.1007/BF00846549.
6. Falba, T., Jofre-Bonet, M., Busch, S., Duchovny, N., & Sindelar, J. (2004). Reduction of quantity smoked predicts future cessation among older smokers. Addiction, 99, 93-102. doi:10.1111/j.1360-0443.2004.00574.x.
7. Gonzales, D. H., Nides, M. A., Ferry, L. H., Kustra, R. P., Jamerson, B. D., Segall, N., et al. (2001). Bupropion SR as an aid to smoking cessation in smokers treated previously with bupropion: A randomized placebo-controlled study. Clinical Pharmacology & Therapeutics, 69, 438-444. doi:10.1067/mcp.2001.115750.
8. Guo, S., Jiang, Z. N., Sun, H. Q., Niu, G. S., Gao, J. Y., Xu, G. Z., et al. (2006). [The smoking cessation efficacy of nicotine sublingual tablet: A double-blind, placebo-controlled trial]. Chinese Journal of Psychiatry, 39, 102-105.
9. Hamilton, M. (1959). The assessment of anxiety states by rating. British Journal of Medical Psychology, 32, 50-55. doi:10.1111/j.2044-8341.1959.tb00467.x.
10. Hesketh, T., Lu, L., Jun, Y. X., & Mei, W. H. (2007). Smoking, cessation and expenditure in low income Chinese: Cross sectional survey. BMC Public Health, 7, 29. doi:10.1186/1471-2458-7-29.
11. Hughes, J., Stead, L., & Lancaster, T. (2004). Antidepressants for smoking cessation. Cochrane Database Systemic Review, 4, CD000031. doi: 10.1002/14651858.CD000031.pub2.
12. Hurt, R. D., Sachs, D. P., Glover, E. D., Offord, K. P., Johnston, J. A., Dale, L. C., et al. (1997). A comparison of sustained-release bupropion and placebo for smoking cessation. New England Journal ofMedicine, 337, 1195-1202. doi:10.1056/NEJM199710233371703.
13. Jiang, J., Liu, B., Sitas, F., Li, J., Zeng, X., Han, W., et al. (2010). Smoking-attributable deaths and potential years of life lost from a large, representative study in China. Tobacco Control, 19, 7-12. doi:10.1136/tc.2009.031245.
14. Jorenby, D. E., Leischow, S. J., Nides, M. A., Rennard, S. I., Johnston, J. A., Hughes, A. R., et al. (1999). A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation. New England Journal of Medicine, 340, 685-691. doi: 10.1056/NEJM199903043400903.
15. Kim, S. S., Chen, W., Kolodziej, M., Wang, X., Wang, V. J., Ziedonis, D., et al. (2012). A systematic review of smoking cessation intervention studies in China. Nicotine & Tobacco Research. doi:10.1093/ntr/ntr289.
16. Lerman, C., Niaura, R., Collins, B. N., Wileyto, P., Audrain-McGovern, J., Pinto, A., et al. (2004). Effect of bupropion on depression symptoms in a smoking cessation clinical trial. Psychology of Addictive Behaviors, 18, 362-366. doi:10.1037/0893-164X.18.4.362.
17. Li, Q., Hsia, J., & Yang, G. (2011). Prevalence of smoking in China in 2010. New England Journal of Medicine, 364, 2469-2470. doi: 10.1056/NEJMc1102459.
18. Mackay, J., Eriksen, M., & Shafey, O. (2006). The tobacco atlas (2nd ed.). Atlanta, GA: American Cancer Society.
19. Pan, J., Jing, W. T., Wang, X. D., & Bai, C. X. (2010). [Psychometric properties of the Chinese version of the Fagerstrom Test of Nicotine Dependence]. International Journal of Respiratology, 30, 266-269.
20. Pang, B. S., Weng, X. Z., Wang, C., Ke, Y. S., Zhang, H. Y., Huang, X. X., et al. (1998). [Correlation of nitric oxide and cotinine in urine of cigarette smokers]. Chinese Journal of Tuberculosis and Respiratory Disease, 4, 245-248.
21. Qian, J., Cai, M., Gao, J., Tang, S., Xu, L., et al. (2010). Trends in smoking and quitting in China from 1993 to 2003: National Health Service Survey data. Bulletin of the World Health Organization, 88, 769-776. doi:10.2471/BLT.09.064709.
22. Sun, H. Q., Guo, S., Chen, D. F., Jiang, Z. N., Liu, Y., et al. (2009). Family support and employment as predictors of smoking cessation success: A randomized, double-blind, placebocontrolled trial of nicotine sublingual tablets in Chinese smokers. American Journal of Drug and Alcohol Abuse, 35, 183-188. doi:10.1080/00952990902839794.
23. US DHHS. (2008). Treating tobacco use and dependence: 2008 update. Rockville, MD.
24. Wang, C., Xiao, D., Chan, K. P., Pothirat, C., Garza, D., Davies, S., et al. (2009). Varenicline for smoking cessation: A placebo-controlled, randomized study. Respirology, 14, 384-392. doi:10.1111/j.1440-1843.2008.01476.x.
25. Yang, G., Ma, J., Chen, A., Zhang, Y., Samet, J. M., Taylor, C. E., et al. (2001). Smoking cessation in China: Findings from the 1996 national prevalence survey. Tobacco Control, 10, 170-174. doi:10.1136/tc.10.2.170.
26. Zhang, M. Y. (1993). [Handbook of rating scales in psychiatry] (1st ed.). Changsha, China: Hunan SciTech Publishing House.